Premium
Anabolic‐Androgenic steroid abuse in weight lifters: Evidence for activation of the hemostatic system
Author(s) -
Ferenchick Gary S.,
Hirokawa Shinchirou,
Mammen Eberhard F.,
Schwartz Kenneth A.
Publication year - 1995
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.2830490405
Subject(s) - steroid use , anabolism , medicine , anabolic steroid , anabolic agents , anabolic androgenic steroids
Anabolic‐androgenic steroid abuse has recently been linked with acute vascular events in athletes. To date, the relationship between steroid abuse and the potential for cardiovascular disease has been considered almost exclusively in terms of lipid metabolism. However, recent reports of thrombosis in androgen abusing athletes with no evidence of atherosclerosis suggests the hypothesis that thrombosis risk in such athletes could be mediated through androgen induced abnormalities of coagulation. To determine if anabolic‐androgenic steroid abuse in weight lifters is associated with an activation of the hemostatic system we studied forty‐nine weight lifters recruited through advertisements. History of androgen use or abstinence was confirmed via urine assays. Plasma was assayed for clotting and fibrinolytic activity by measuring thrombin/ antithrombin complexes (TAT), prothrombin fragment 1 + 2 (F1 + 2), and D‐dimers (D‐di); markers of the endothelial based fibrinolytic components were assayed by measuring tissue plasminogen activator antigen (t‐PA Ag) and its inhibitor (PAI‐1); finally, the activity of antithrombin III, protein C, and protein S were measured. Abnormally high concentrations of TAT complexes were noted in 16% of our confirmed steroid using weight lifters compared to 6% of our confirmed nonusers ( P = .01). Steroid users also demonstrated abnormally high concentrations of F1 + 2 and D‐dimers when compared to nonusers (44 vs. 24%, P < .001, and 9 vs. 0%, respectively). Non‐steriod users were more likely to have elevated levels of t‐PA Ag and PAI‐1 than our steroid using weight lifters (both P < .001). The activities of antithrombin III and protein S were more likely to be higher in users compared to nonusers (22 vs. 6%, P = .005; 19 vs. 0%, respectively). Some anabolic‐androgenic steroid using weight lifters have an accelerated activation of their hemostatic system as evidenced by increased generation of both thrombin and plasmin. These changes could reflect a thrombotic diathesis that may contribute to vascular occlusion reported in young athletes using these drugs. The predictive value of these coagulation abnormalities in terms of risk of thrombosis to individual steroid using weight lifters or the population as a whole remains to be studied. © 1995 Wiley‐Liss, Inc.